Introduction
============

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and is associated with increased morbidity and mortality. The diagnosis of airflow limitation in COPD patients is based on the ratio of forced expiratory volume in 1 s (FEV~1~) to forced vital capacity (FVC); however, the severity of an airflow limitation is classified on the basis of FEV~1~, which was a predictor of mortality in COPD patients.[@b1-copd-11-2785]--[@b3-copd-11-2785] Mild-to-moderate COPD is generally classified as an FEV~1~ ≥50% of the normal predicted value and an FEV~1~/FVC \<0.7.[@b4-copd-11-2785]

Pulmonary complications, which are common after major abdominal surgery, increase mortality, length of hospital stay, intensive care unit (ICU) cares, hospital readmissions, and medical cost.[@b5-copd-11-2785]--[@b7-copd-11-2785] Identification of the risk factors for predicting postoperative pulmonary complications (PPCs) is essential to provide proper perioperative management. Importantly, COPD has been previously shown to be associated with PPCs. Previous studies have shown that the prevalence of PPCs and the postoperative mortality rate increased in patients with COPD following general and thoracic surgery.[@b8-copd-11-2785]--[@b11-copd-11-2785] However, in the majority of these studies, COPD was defined as clinically symptomatic COPD or severe-to-very severe COPD. Recent data have shown that patients with asymptomatic or mild airflow limitation could be diagnosed at earlier stages and that the overwhelming majority of COPD cases consist of patients with mild-to-moderate COPD.[@b12-copd-11-2785] Until recently, the role of mild-to-moderate COPD in the development of PPCs was not studied well. Therefore, studies that assess the role of mild-to-moderate COPD are critical to provide accurate and appropriate perioperative management to patients. Furthermore, information on the relationship between mild-to-moderate COPD and PPCs is limited. In order to address this problem, patients who underwent abdominal surgery were retrospectively reviewed, and whether mild-to-moderate COPD was associated with the prevalence of PPC was evaluated. In addition, various candidate risk factors were investigated to determine whether they were good predictors of PPCs.

Materials and methods
=====================

Study design and patients
-------------------------

This retrospective cohort study was approved by the Institutional Review Board (2016-0428) of Asan Medical Center, which waived the need for informed consent. The medical records of patients who underwent abdominal surgery between January 2015 and December 2015 were reviewed, and the following data were extracted: demographic characteristics, comorbidities, spirometry results, preoperative respiratory symptoms, and operative conditions such as the lengths of anesthesia and surgery, surgical methods, surgical sites, surgical emergency, and the amount of perioperative red blood cell (RBC) transfusion. PPCs and postoperative care were also reviewed.

Patients who met the following criteria were included in the present study: preoperative pulmonology consultation because of comorbidity, old age, or abnormal lung function; abdominal surgery under general anesthesia; and age ≥40 years. Patients with the following characteristics were excluded from the final analysis: those without a lung function test within 1 month of surgery, those who underwent nonabdominal surgery or abdominal surgery in combination with thoracic surgery, those with a history of asthma or asthma--COPD overlap syndrome (ACOS), those who received preoperative mechanical ventilator care, and those with an unknown smoking history.

Definitions
-----------

COPD was defined as FEV~1~/FVC of \<0.7 by preoperative spirometry evaluation. COPD patients were classified into two groups according to the severity defined by spirometry findings on the basis of Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. Mild-to-moderate COPD was defined as FEV~1~ ≥50% of predicted value, and severe-to-very severe COPD was defined as FEV~1~ \<50% of predicted value. Among patients with FEV~1~/FVC ≥0.7, those with FVC \<80% of predicted value were found to have pulmonary disease with restrictive pattern, and those with FVC ≥80% of predicted value were defined as control subjects.

Abdominal surgery was classified into four categories based on the abdominal regions: upper abdominal, colorectal, genitourinary surgery, and others, by using the previously defined grouping method.[@b13-copd-11-2785] Upper abdominal surgery included gastrectomy, pancreatectomy, hepatic resection, cholecystectomy, splenectomy, and excision of diaphragm, but esophagectomy was excluded. The amount of RBC transfusion during the perioperative period was estimated by the number of prepared packed RBCs between the day of surgery and the end of the first day after surgery. Surgeries were also categorized as emergency and scheduled, based on the surgical records.

The definition of PPCs was modified and applied from a previous study.[@b14-copd-11-2785] PPCs included new-onset pneumonia, pulmonary edema, pulmonary thromboembolism, atelectasis, and acute exacerbation of COPD after surgery. Postoperative pneumonia was defined as new development of pulmonary infiltration on chest X-ray, acute respiratory symptoms, fever or elevated inflammatory markers, and requirement of antibiotic treatment. Pulmonary edema was defined as the presence of postoperative dyspnea with radiologically diagnosed pulmonary interstitial fluid accumulation or cardiomegaly or impaired cardiac function confirmed by echocardiography. Pulmonary thromboembolism was defined as postoperative dyspnea with decreased PaO~2~ on arterial blood gas analysis and the presence of thromboembolism on chest computed tomography. Atelectasis was defined as large-sized atelectasis of lobar involvement on chest X-ray. In COPD patients, episodes with postoperative wheezing requiring bronchodilator or glucocorticoid treatment were defined as acute exacerbation of COPD.

Statistical analysis
--------------------

The characteristics of study subgroups were compared by using analysis of variance, Kruskal--Wallis test, unpaired *t*-test, or the Mann--Whitney *U*-test for continuous variables, and Fisher's exact test was used for categorical variables. Variables with significance by univariate analysis and previously known risk factors, including age, male gender, body mass index (BMI), Charlson comorbidity index (CCI) score, American Society of Anesthesiologists (ASA) physical status score, previous hospitalization because of respiratory problems, blood urea nitrogen (BUN), emergency surgery, length of anesthesia, RBC transfusion, laparoscopic surgery, upper abdominal surgery, and spirometry findings, were evaluated by using multivariate analysis to determine the independent predictors of PPCs. Multivariate analysis using binary logistic regression was conducted by using all the variables mentioned above and also by using stepwise backward elimination method. First, all the variables related to an increased risk of PPCs were analyzed. Then, by using a stepwise backward elimination method, independent predictors of PPCs were determined. In order to confirm the role of mild-to-moderate COPD in the development of PPCs, the ever-smoker subgroup without a restrictive pattern was analyzed by using a sensitivity analysis. Statistical analyses were performed by using Statistical Package for the Social Sciences^®^ Version 22.0 (IBM Corporation, Armonk, NY, USA). Data were expressed as mean ± standard deviation or medians and interquartile ranges (IQRs), and *P*-values \<0.05 were considered significant.

Results
=======

Baseline and operative characteristics
--------------------------------------

Among a total of 468 eligible patients, 81 patients were excluded from the final analysis ([Figure 1](#f1-copd-11-2785){ref-type="fig"}). [Table 1](#t1-copd-11-2785){ref-type="table"} shows the baseline characteristics of a total of 387 patients included in the present study. In this cohort, 258 (66.7%) patients were male with a median age of 69.0 years (range, 40--90 years). Overall median BMI was 23.0 kg/m^2^ (IQR =20.6--25.4 kg/m^2^). One hundred and ninety-seven (50.9%) patients were ever-smokers with a median smoking history of 30.0 pack-years (IQR =20.0--40.0 pack-years). Median ASA physical status score was 2.0 (IQR, 2.0--3.0), and 93.8% patients scored 1--3. Median CCI score (unadjusted for age) in this cohort was 3.0 (IQR =2.0--4.0). History of hospitalization for respiratory problems within 1 year of surgery was found in 24 (6.2%) patients, respectively.

Lung function characteristics of the study subjects were as follows: median FVC, FEV~1~, and FEV~1~/FVC values were 2.8 L (IQR =2.1--3.4 L; 74.0% predicted \[IQR =59.0%--86.0% predicted\]), 1.9 L (IQR =1.4--2.4 L; 69.0% predicted \[IQR =56.5%--86.0% predicted\]), and 0.73 (IQR =0.64--0.80), respectively. Among a total of 387 patients included in the final analysis, 151 (39.0%) patients with obstructive spirometry pattern were divided into two categories: mild-to-moderate COPD was found in 117 (30.2%) patients and 34 (8.8%) patients had severe-to-very-severe COPD. Restrictive spirometry pattern was observed in 150 (38.8%) patients.

[Table 2](#t2-copd-11-2785){ref-type="table"} shows abdominal surgery characteristics of the subjects. Forty-one (10.6%) patients underwent emergency abdominal surgery; the remaining patients underwent elective surgery. Laparoscopic surgery was performed in 145 (37.5%) patients. Upper abdominal area (71.1%) was the most commonly operated site in this study. Overall median length of anesthesia and surgery from incision to skin closure were determined as 205.0 (IQR =116--328) and 145.0 (IQR =75--264) min, respectively. In the perioperative period, a median of 2.0 (IQR =0.0--2.0) packs of RBCs were used for transfusion.

PPCs
----

[Table 3](#t3-copd-11-2785){ref-type="table"} summarizes data on PPCs and postoperative management. Among a total of 387 patients who underwent abdominal surgery, PPCs occurred in 63 (16.3%) patients. The most common PPCs were pneumonia (8.3%) and pulmonary edema (6.5%). Other PPCs included atelectasis (4.9%), pulmonary thromboembolism (0.5%), and acute exacerbation of COPD (0.3%).

Among the entire cohort, 81 (20.9%) patients required intensive care during the postoperative period, and 57 (14.7%) patients received support by mechanical ventilation in ICU. The median duration of ICU stay was 4.0 (IQR =1.0--14.0) days, and the median number of days on a ventilator was 3.0 (IQR =2.0--14.0). Prolonged mechanical ventilation (\>3 days) was needed for 34 patients (59.6% in patients with ventilator care). The most common cause of ICU care was complications associated with surgery (66.7% in patients with ICU care), and 27 patients (33.3% in patients with ICU care) required ICU care because of respiratory problems. After discharge, 31 (8.1%) patients required readmission; however, respiratory problems were not a common cause of readmission (only three patients). Mortality rate, including in-hospital and within 30 days after hospital discharge, was estimated to be 2.6%.

Comparison between patients with mild-to-moderate COPD and control subjects
---------------------------------------------------------------------------

There were no significant differences in PPCs (*P*=0.657) or requirement for intensive care, including ICU care (*P*=0.590) and mechanical ventilator support (*P*=0.506), between patients with mild-to-moderate COPD and control subjects, as shown in [Table 3](#t3-copd-11-2785){ref-type="table"}. Patients with mild-to-moderate COPD were older than control subjects (*P*\<0.001) and were predominantly male (*P*\<0.001). There were more ever-smokers among patients with COPD than control subjects (*P*\<0.001); however, there was no significant difference in smoking duration between the groups (*P*=0.171). Patients with mild-to-moderate COPD had more comorbidities assessed by age-adjusted CCI score (*P*=0.043) and higher serum creatinine levels (*P*=0.003) than control subjects. There were more patients with poor physical status among those with mild-to-moderate COPD (*P*=0.045). Furthermore, deterioration in lung function was significantly worse (*P*\<0.001), and dyspnea was significantly more frequent (*P*=0.039) in the mild-to-moderate COPD group than in the control group.

Risk factors for PPCs
---------------------

Surprisingly, contrary to the findings of previous studies, mild-to-moderate COPD was not associated with an increased rate of PPCs by either univariate or multivariate analyses ([Table 4](#t4-copd-11-2785){ref-type="table"}). Accordingly, whether mild-to-moderate COPD increased the risk of PPCs was determined, and factors that could predict PPCs were identified. Applying the variables (see the "Statistical Analysis" section) to risk-adjusted analysis, the present study found that there was an increased risk of PPCs associated with a history of hospitalization for respiratory problems (*P*=0.012), emergency surgery (*P*=0.001), and amount of RBC transfusion (*P*=0.008).

Then, stepwise backward elimination was used to identify the best combination of risk factors for predicting PPCs. PPCs were independently predicted by six variables, including poor ASA physical status (OR =1.60; 95% CI =0.97--2.63; *P*=0.065), history of hospitalization for respiratory problems (OR =4.20; 95% CI =1.52--11.59; *P*=0.006), emergency surgery (OR =3.93; 95% CI =1.75--8.82; *P*=0.001), amount of RBC transfusion (OR =1.09; 95% CI =1.05--1.14; *P*\<0.001 for one pack increase of RBC transfusion), laparoscopic surgery (OR =0.41; 95% CI =0.18--0.93; *P*=0.033), and severe-to-very severe COPD (OR =3.47; 95% CI =1.16--10.42; *P*=0.027). In this analysis, mild-to-moderate COPD was not a significant predictor of PPCs (*P*=0.628).

Risk factors for PPCs in ever-smokers
-------------------------------------

In order to confirm that mild-to-moderate COPD was not a predictor of PPCs, subgroup analysis was performed in ever-smoker patients excluding those with a restrictive pattern disease ([Table 5](#t5-copd-11-2785){ref-type="table"}), which revealed that mild-to-moderate COPD was not associated with an increased risk of PPCs. CCI scores were higher, hospitalization stays due to respiratory illness and emergency surgery were more frequent, and there were more RBC transfusions among smokers with PPCs than those without PPCs (data not shown).

Multivariate analysis using all the variables demonstrated that a history of hospitalization for respiratory problems (*P*=0.001) was significantly associated with PPCs. According to the multivariate analysis by using stepwise backward elimination, a history of hospitalization for respiratory problems (OR =18.75; 95% CI =3.47--101.25; *P*=0.001) and a higher amount of RBCs for transfusion (OR =1.17; 95% CI =1.02--1.34; *P*=0.023, for one pack increase of RBC transfusion) were independent predictors of PPCs. However, as consistent with results from analysis that included all the study subjects, mild-to-moderate COPD was not a risk factor for PPCs (*P*=0.152) by subgroup analysis.

Comparison between patients with and without PPCs
-------------------------------------------------

[Tables S1](#SD1-copd-11-2785){ref-type="supplementary-material"} and [S2](#SD2-copd-11-2785){ref-type="supplementary-material"} present the characteristics and surgical data of patients with and without PPCs. There were more PPCs in patients with lower BMI (*P*=0.049), poor ASA physical status (*P*\<0.001), more medical comorbidities (ie, high CCI scores; *P*\<0.001), history of hospitalization for respiratory causes (*P*=0.009), increased BUN (*P*=0.001) and creatinine (*P*=0.009), emergency surgery (*P*\<0.001), nonlaparoscopic surgery (*P*\<0.001), longer duration of anesthesia or surgery (*P*\<0.001), and more RBC transfusions (*P*\<0.001). However, abnormal preoperative spirometry findings, such as obstructive and restrictive patterns, and severity of obstruction were not associated with the prevalence of PPCs. There were no differences in age, gender, smoking history, respiratory symptoms, lung functions, or frequency of upper abdominal surgeries between patients with and without PPCs.

There were several differences in postoperative outcomes between patients with and without PPCs ([Table S3](#SD3-copd-11-2785){ref-type="supplementary-material"}). Patients with PPCs had a higher frequency and a longer duration of intensive care or mechanical ventilator support than those without PPCs. In addition, patients who received prolonged ventilator care had more PPCs. As part of the extended intensive care management, these patients had longer hospi-talization times and delayed discharge. In-hospital mortality rate was also higher (11.1%) among patients with PPCs than those without PPCs (0.6%). Among these, only three patients had respiratory problems as a cause of death.

Discussion
==========

Previous reports have shown that patients with COPD are at an increased risk of pulmonary complications after abdominal surgery.[@b7-copd-11-2785],[@b8-copd-11-2785],[@b15-copd-11-2785] However, information on the relationship between PPCs and mild-to-moderate COPD remains limited. Therefore, in the present study, COPD patients who underwent abdominal surgery were investigated to determine whether mild-to-moderate COPD was associated with an increased risk of PPCs. Among a total of 387 patients who were included in the present study, 117 (30.2%) patients had mild-to-moderate COPD; however, there was no increased risk of PPCs, including pneumonia, pulmonary edema, pulmonary thromboembolism, atelectasis, and acute exacerbation of COPD.

The underlying mechanisms of PPCs are unclear,[@b16-copd-11-2785] but previous reports have shown that COPD is an independent risk factor for PPCs in addition to other morbidities.[@b8-copd-11-2785],[@b15-copd-11-2785] Numerous studies have shown that severe COPD was associated with an increased prevalence of PPCs in various settings.[@b7-copd-11-2785],[@b9-copd-11-2785],[@b10-copd-11-2785] Yet, most COPD patients suffer from the mild-to-moderate variant of the disease, and comorbidities were more common in mild-to-moderate COPD than in severe COPD.[@b12-copd-11-2785],[@b17-copd-11-2785] Thus, the medical team, including surgeons, anesthesiologists, and pulmonologists, has ample opportunity to evaluate patients with mild-to-moderate COPD for potential PPCs. In the present study, mild-to-moderate COPD was not associated with PPCs. There was no significant difference in the prevalence rate of PPCs between patients with mild-to-moderate COPD and control patients. In contrast, patients with severe-to-very severe COPD appeared to have more frequent PPCs than those without COPD or control subjects, although this finding did not reach a statistical significance. The risk-adjusted analysis also showed that mild-to-moderate COPD was not an independent risk factor for PPCs.

In the present study, PPCs occurred in 16.3% of the entire cohort and were found in 15.1% of the control subjects and 12.0% of the patients with mild-to-moderate COPD. PPCs were the second most common type of complication after surgery, and the incidence of PPC was increased in patients with respiratory diseases, ranging between 25% and 90%.[@b7-copd-11-2785],[@b18-copd-11-2785] However, the difference in incidence rates may result from selection bias because of differences in the characteristics of hospitals and study populations. The hospital in the present study was a relatively large-sized referral center and was one of the preferred hospitals in the region for major abdominal surgery. Thus, a large variety of difficult and complicated surgical cases such as liver transplantation and Whipple or pylorus-preserving pancreaticoduodenectomy were included. Furthermore, PPCs were diversely defined from transient hypoxia and bronchospasm to long-term respiratory failure, including weaning failure and reintubation.[@b7-copd-11-2785],[@b8-copd-11-2785],[@b15-copd-11-2785],[@b19-copd-11-2785] In the present study, the PPCs were first defined as postoperative pneumonia, pulmonary edema, pulmonary thromboembolism, atelectasis, and acute exacerbation of COPD. Then, the reason for postoperative respiratory distress could concretely be found out by these five categories of PPCs. A variable, prolonged ventilator care over 3 days was used to estimate postoperative respiratory failure, but still had a limitation to compare postoperative respiratory failure across papers.

A previous study indicated that the specific type and site of surgery were more significantly associated with an increased PPC risk than the preoperative pulmonary condition of the patient.[@b7-copd-11-2785] Upper abdominal surgery plays an important role in postoperative diaphragmatic dysfunction, a well-known cause of PPCs.[@b14-copd-11-2785],[@b19-copd-11-2785]--[@b22-copd-11-2785] However, the study included esophagectomy, which has the highest rate of pulmonary complications and is commonly performed via the thoracic approach. Therefore, the present study strictly defined abdominal surgery as hepatobiliary, pancreatic, and gastric surgery and excluded esophagectomy. Accordingly, upper abdominal surgery was not a risk factor for PPCs in the present study.

Nonetheless, surgical or anesthesia-related factors remain important predictors of PPCs. There are contradictory reports about the effect of laparoscopic surgery on intraoperative or postoperative pulmonary mechanics.[@b23-copd-11-2785]--[@b25-copd-11-2785] However, meta-analyses showed that patients who underwent laparoscopic surgery had better preservation of lung function and lower rates of pulmonary complications than those who underwent open surgery.[@b26-copd-11-2785],[@b27-copd-11-2785] Risk-adjusted analysis of patients in the present study supported the previous data showing that laparoscopic surgery could prevent PPCs. Under prolonged anesthesia, the combined effect of the supine position and exposure to general anesthetics can lead to an immediate decline in lung volume and alter immune responses and gas exchange capacity.[@b16-copd-11-2785] Several previous studies have shown that both prolonged surgery and anesthesia were risk factors for PPCs.[@b7-copd-11-2785],[@b19-copd-11-2785],[@b28-copd-11-2785] The present study showed that the duration of anesthesia and surgery were longer in patients with PPCs; however, neither was an independent predictor for PPCs in multivariate analysis.

Patients undergoing emergency surgery have shown higher rates of mortality as well as respiratory failure than nonemergent surgery patients.[@b19-copd-11-2785],[@b29-copd-11-2785] In agreement with these earlier findings, the present study observed that emergency surgery significantly increased the risk of PPCs and respiratory failure. Moreover, among surgery-related variables, emergency surgery was one of the strongest predictors of PPCs. Perioperative blood loss can also occur because of technical difficulty of surgery, in addition to the medical status of patients. A previous study of COPD patients showed that estimated blood loss was a risk factor in PPCs.[@b14-copd-11-2785] In the present study, blood loss was estimated by the amount of prepared RBCs in the perioperative period. Patients with PPCs needed more RBC transfusions, which was an independent predictor of PPCs not only in the ever-smoker subgroup by a risk-adjusted analysis, but also among the entire cohort. Meanwhile, in a study about postoperative ARDS, the postoperative ARDS might be caused by transfusion-related acute lung injury, or massive transfusion itself might be an indicator of more aggressive resuscitation and predictive of future ARDS.[@b30-copd-11-2785]

Although several studies have shown that advanced age, smoking, obesity, and gender could impact postoperative complications,[@b7-copd-11-2785],[@b15-copd-11-2785],[@b22-copd-11-2785],[@b31-copd-11-2785] they have yet to be a consensus on these issues because of the limited study populations and scope of surgery type. However, one of the most important factors impacting postoperative outcome is the physical status of patients, including comorbidity. In the present study, patients with PPCs had higher ASA physical status and CCI scores. Among these patients, the predictive ability of ASA physical status score was not statistically significant. On the other hand, patients with PPCs had more episodes of hospitalization for respiratory illness. The present study found that a history of hospitalization for respiratory illness was the most powerful predictor of PPCs after surgery in ever-smoker subgroup as well as overall subjects in this study. The history of hospitalization for respiratory illness is a unique finding as a risk factor to predict PPCs. However, this result suggests that preoperative pulmonary status is also weighty according to other papers.[@b19-copd-11-2785],[@b28-copd-11-2785] Thus, even patients with no respiratory symptoms, a history of hospitalization for respiratory illness should be carefully assessed in preoperative stage.

The present study has several limitations. First, this was a retrospective study performed at a single center. Second, the low number of study subjects may have affected the statistical power of comparisons. A prospective multicenter study with a broad spectrum of patients, ranging from those with normal lung functions to patients with very severe COPD, is required to confirm the results of the present study. Third, the preoperative spirometry used to evaluate study subjects was not a routine practice for all surgical candidates; only those with respiratory symptoms, a history of respiratory illness, and advanced age were assessed by preoperative spirometry and received consultation from a pulmonologist. Therefore, the possibility of respiratory problems and complications was higher in the present study population than in the general population. In addition, preoperative conditions such as abdominal pain and abdominal inflammation could affect preoperative spirometry findings. Underestimation of spirometry results could lead to the inappropriate classification of patients. Thus, longitudinal studies using routine spirometry for all the subjects are required to evaluate the relationship between lung function and PPCs in ordinary times. Finally, prebronchodilator spirometry results were used without consideration of smoking history or exposure of other risk factors for COPD diagnosis; as per GOLD guidelines, this is not the recommended method of diagnosis. Several studies have shown that both the prevalence and incidence of COPD in the general population decreased substantially when COPD was defined on the basis of postbronchodilator spirometry values rather than prebronchodilator values.[@b32-copd-11-2785],[@b33-copd-11-2785] However, changes in FEV~1~ and FEV~1~/FVC values following bronchodilator use also decreased with age.[@b34-copd-11-2785] As the study population in the present study consisted of relatively old patients, and given that subjects with a history of asthma or ACOS were excluded, the effect of bronchodilator use on the present findings was likely limited. In addition, the data showed that control subjects had fewer smokers and relatively shorter duration of smoking, compared to those with COPD. Furthermore, ever-smoker subgroup analysis was performed to increase the reliability of the present findings, which supported the initial finding that the role of mild-to-moderate COPD in PPCs was insignificant. Well-designed prospective studies with results of postbronchodilator spirometry and analysis of COPD risk factors are necessary to confirm that mild-to-moderate COPD was not associated with PPCs in patients who underwent abdominal surgery.

Conclusion
==========

In conclusion, 12.0% of patients with mild-to-moderate (FEV~1~ ≥50% of predicted value) COPD suffered from PPCs after abdominal surgery; PPCs were observed in 15.1% of control subjects. Mild-to-moderate COPD was not associated with an increased risk of PPCs, even after adjusting for covariates. In the present study, a history of hospitalization for respiratory illness within the previous year, emergency surgery, and amount of RBCs for transfusion were the major significant risk factors for PPCs after abdominal surgery.

Supplementary materials
=======================

###### 

Comparison of baseline characteristics in patients with and without postoperative pulmonary complications

                                                                                           No postoperative pulmonary complications (n=324)   Postoperative pulmonary complications (n=63)   *P*-value
  ---------------------------------------------------------------------------------------- -------------------------------------------------- ---------------------------------------------- -----------
  Age (years)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                                 69.0 (61.0, 75.0)                                  68.0 (60.5, 74.0)                              0.411
  Gender (male)                                                                            210 (64.8)                                         48 (76.2)                                      0.108
  Smoking history                                                                                                                                                                            0.894
   Never                                                                                   160 (49.4)                                         30 (47.6)                                      
   Current smoker                                                                          49 (15.1)                                          11 (17.5)                                      
   Past-smoker                                                                             115 (35.5)                                         22 (34.9)                                      
  Pack-years[a](#tfn22-copd-11-2785){ref-type="table-fn"}                                  30.0 (20.0, 40.0)                                  30.0 (20.0, 45.0)                              0.920
  Body mass index (kg/m^2^)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                   23.2 (20.8, 25.4)                                  22.0 (19.5, 24.6)                              0.049
  Charlson comorbidity index[a](#tfn22-copd-11-2785){ref-type="table-fn"}                  2.0 (2.0, 4.0)                                     3.0 (3.0, 4.0)                                 \<0.001
  Charlson comorbidity index (age-adjusted)[a](#tfn22-copd-11-2785){ref-type="table-fn"}   5.0 (4.0, 6.5)                                     6.0 (5.0, 7.0)                                 0.007
  ASA physical status                                                                                                                                                                        \<0.001
   1                                                                                       25 (7.7)                                           0 (0.0)                                        
   2                                                                                       214 (66.0)                                         30 (47.6)                                      
   3                                                                                       72 (22.2)                                          22 (34.9)                                      
   4                                                                                       13 (4.0)                                           11 (17.5)                                      
  History                                                                                                                                                                                    
   Upper respiratory infection                                                             8 (2.5)                                            2 (3.2)                                        1.000
   Hospitalization due to respiratory problem                                              15 (4.6)                                           9 (14.3)                                       0.009
   Exacerbation of COPD                                                                    2 (0.6)                                            1 (1.6)                                        0.985
  Respiratory symptoms                                                                     59 (18.2)                                          9 (14.3)                                       0.570
   Chronic cough                                                                           27 (8.3)                                           2 (3.2)                                        0.245
   Chronic sputum                                                                          19 (5.9)                                           2 (3.2)                                        0.577
   Dyspnea (mMRC)                                                                                                                                                                            0.096
    1                                                                                      10 (3.1)                                           1 (1.6)                                        
    2                                                                                      21 (6.5)                                           1 (1.6)                                        
    3                                                                                      4 (1.2)                                            3 (4.9)                                        
    4                                                                                      0 (0.0)                                            0 (0.0)                                        
  Laboratory finding                                                                                                                                                                         
   Blood urea nitrogen (mg/dL)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                14.0 (10.0, 17.5)                                  16.0 (12.5, 22.5)                              0.001
   Creatinine (mg/dL)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                         0.8 (0.6, 0.9)                                     0.9 (0.7, 1.1)                                 0.009
   Albumin (g/dL)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                             3.3 (2.9, 3.6)                                     3.3 (2.9, 3.7)                                 0.384
  Preoperative spirometry                                                                                                                                                                    
   FVC (L)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                                    2.8 (2.1, 3.4)                                     2.8 (2.1, 3.3)                                 0.903
   FVC (% pred)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                               73.8±19.3                                          71.4±18.3                                      0.356
   FEV (L)[a](#tfn22-copd-11-2785){ref-type="table-fn"} 1                                  1.9 (1.5, 2.4)                                     1.8 (1.4, 2.4)                                 0.813
   FEV~1~ (% pred)[a](#tfn22-copd-11-2785){ref-type="table-fn"}                            69.0 (57.0, 87.0)                                  71.0 (53.5, 81.5)                              0.437
   FEV~1~/FVC[a](#tfn22-copd-11-2785){ref-type="table-fn"}                                 0.73 (0.63, 0.80)                                  0.76 (0.64, 0.82)                              0.624
   DLco (% pred)[b](#tfn23-copd-11-2785){ref-type="table-fn"}                              65.2±20.1                                          44.9±17.1                                      0.014

**Notes:** Data are presented as numbers (%) unless otherwise indicated.

Median (interquartile range),

mean ± standard deviation.

**Abbreviations:** ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; DLco, diffusing capacity for carbon monoxide; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; mMRC, modified Medical Research Council Dyspnea Scale; pred, predicted.

###### 

Differences in surgical characteristics between patients with and without postoperative pulmonary complications

                                                                              No postoperative pulmonary complications (n=324)   Postoperative pulmonary complications (n=63)   *P*-value
  --------------------------------------------------------------------------- -------------------------------------------------- ---------------------------------------------- -----------
  Emergency operation                                                         22 (6.8)                                           19 (30.2)                                      \<0.001
  Anesthesia time (min)[a](#tfn26-copd-11-2785){ref-type="table-fn"}          190.0 (110.0, 300.0)                               310.0 (157.5, 687.5)                           \<0.001
  Incision to close time (min)[a](#tfn26-copd-11-2785){ref-type="table-fn"}   132.0 (68.5, 243.5)                                230.0 (115.0, 575.0)                           \<0.001
  Laparoscopic surgery                                                        135 (41.7)                                         10 (15.9)                                      \<0.001
  Upper abdominal surgery                                                     230 (71.0)                                         45 (71.4)                                      1.000
  RBCs for transfusion (pack)[a](#tfn26-copd-11-2785){ref-type="table-fn"}    2.0 (0.0, 2.0)                                     3.0 (2.0, 16.5)                                \<0.001

**Notes:** Data are presented as numbers (%) unless otherwise indicated.

Median (interquartile range).

**Abbreviation:** RBC, red blood cell.

###### 

Differences in postoperative management and outcomes between patients with and without postoperative pulmonary complications

                                                                                        No postoperative pulmonary complications (n=324)   Postoperative pulmonary complications (n=63)   *P*-value
  ------------------------------------------------------------------------------------- -------------------------------------------------- ---------------------------------------------- -----------
  ICU admission                                                                         41 (12.7)                                          40 (63.5)                                      \<0.001
  Length of ICU admission (days)[a](#tfn29-copd-11-2785){ref-type="table-fn"}           2.0 (1.0, 6.0)                                     13.0 (4.0, 28.5)                               \<0.001
  Ventilator care                                                                       23 (7.1)                                           34 (54.0)                                      \<0.001
  Length of ventilator care (days)[a](#tfn29-copd-11-2785){ref-type="table-fn"}         2.0 (1.0, 3.0)                                     12.0 (3.0, 31.0)                               0.003
  Ventilator care in over 3 days                                                        8 (34.8)                                           26 (76.5)                                      0.004
  Readmission within 30 days                                                            25 (7.8)                                           6 (9.5)                                        0.829
  Readmission due to respiratory cause                                                  0 (0.0)                                            3 (50.0)                                       0.003
  In-hospital mortality                                                                 2 (0.6)                                            7 (11.1)                                       \<0.001
  In-hospital mortality + mortality within 30 days                                      3 (0.9)                                            7 (12.1)                                       \<0.001
  Overall mortality                                                                     7 (2.2)                                            9 (15.5)                                       \<0.001
  Duration operation to discharge (days)[a](#tfn29-copd-11-2785){ref-type="table-fn"}   8.0 (5.0, 13.0)                                    26.0 (13.0, 43.5)                              \<0.001
  Duration admission to discharge (days)[a](#tfn29-copd-11-2785){ref-type="table-fn"}   16.0 (11.0, 24.0)                                  41.0 (24.0, 61.5)                              \<0.001

**Notes:** Data are presented as numbers (%) unless otherwise indicated.

Median (interquartile range).

**Abbreviation:** ICU, intensive care unit.
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###### 

Baseline characteristics of study subjects classified by preoperative spirometry findings

                                                                                          Control (n=86)       Mild-to-moderate COPD (n=117)   Severe-to-very severe COPD (n=34)   Restrictive (n=150)
  --------------------------------------------------------------------------------------- -------------------- ------------------------------- ----------------------------------- ---------------------
  Age (years)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                                 63.0 (57.0, 72.0)    69.0 (63.0, 75.0)               74.0 (71.0, 77.0)                   68.0 (60.0, 75.0)
  Gender (male)                                                                           45 (52.3)            100 (85.5)                      29 (85.3)                           84 (56.0)
  Smoking history                                                                                                                                                                  
   Never                                                                                  57 (66.3)            36 (30.8)                       5 (14.7)                            92 (61.3)
   Current smoker                                                                         7 (8.1)              31 (26.5)                       6 (17.6)                            16 (10.7)
   Past-smoker                                                                            22 (25.6)            50 (42.7)                       23 (67.6)                           42 (28.0)
  Pack-years[a](#tfn2-copd-11-2785){ref-type="table-fn"}                                  26.2 (15.0, 42.5)    30.0 (20.0, 47.0)               37.5 (25.0, 40.0)                   30.0 (18.5, 40.0)
  Body mass index (kg/m^2^)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                   22.7 (20.5, 24.6)    23.0 (21.0, 24.8)               22.4 (20.6, 25.2)                   23.5 (20.3, 26.1)
  Charlson comorbidity index[a](#tfn2-copd-11-2785){ref-type="table-fn"}                  3.0 (2.0, 4.0)       3.0 (2.0, 5.0)                  3.0 (2.0, 4.0)                      3.0 (1.0, 4.0)
  Charlson comorbidity index (age-adjusted)[a](#tfn2-copd-11-2785){ref-type="table-fn"}   5.0 (4.0, 6.0)       5.0 (4.0, 7.0)                  6.0 (5.0, 7.0)                      5.0 (4.0, 6.0)
  ASA physical status                                                                                                                                                              
   1                                                                                      2 (2.3)              9 (7.7)                         4 (11.8)                            10 (6.7)
   2                                                                                      68 (79.1)            72 (61.5)                       24 (70.6)                           80 (53.3)
   3                                                                                      14 (16.3)            29 (24.8)                       4 (11.8)                            47 (31.3)
   4                                                                                      2 (2.3)              7 (6.0)                         2 (5.9)                             13 (8.7)
  History                                                                                                                                                                          
   Upper respiratory infection                                                            3 (3.5)              4 (3.4)                         0 (0.0)                             3 (2.0)
   Hospitalization due to respiratory problem                                             5 (5.8)              8 (6.8)                         3 (8.8)                             8 (5.3)
   Exacerbation of COPD                                                                   0 (0.0)              0 (0.0)                         3 (8.8)                             0 (0.0)
  Respiratory symptoms                                                                    10 (11.6)            26 (22.2)                       14 (41.2)                           18 (12.0)
   Chronic cough                                                                          7 (8.1)              10 (8.5)                        6 (17.6)                            6 (4.0)
   Chronic sputum                                                                         4 (4.7)              7 (6.0)                         5 (14.7)                            5 (3.3)
   Dyspnea (mMRC)                                                                                                                                                                  
    1                                                                                     1 (1.2)              3 (2.6)                         4 (12.1)                            3 (2.0)
    2                                                                                     1 (1.2)              8 (6.9)                         7 (21.2)                            6 (4.0)
    3                                                                                     1 (1.2)              3 (2.6)                         1 (3.0)                             2 (1.3)
    4                                                                                     0 (0.0)              0 (0.0)                         0 (0.0)                             0 (0.0)
  Laboratory finding                                                                                                                                                               
   Blood urea nitrogen (mg/dL)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                14.0 (11.0, 17.0)    14.0 (11.0, 18.0)               13.5 (9.0, 21.0)                    14.0 (10.0, 18.0)
   Creatinine (mg/dL)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                         0.7 (0.6, 0.9)       0.8 (0.7, 1.0)                  0.8 (0.7, 1.0)                      0.8 (0.6, 1.0)
   Albumin (g/dL)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                             3.4 (3.0, 3.7)       3.3 (3.0, 3.7)                  3.0 (2.8, 3.3)                      3.1 (2.8, 3.5)
  Preoperative spirometry                                                                                                                                                          
   FVC (L)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                                    3.2 (2.7, 4.0)       3.2 (2.8, 3.7)                  2.4 (2.0, 2.8)                      2.1 (1.7, 2.7)
   FVC (% pred)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                               90.5 (83.0, 99.0)    80.0 (70.0, 91.0)               60.0 (49.0, 71.0)                   59.0 (52.0, 68.0)
   FEV~1~ (L)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                                 2.5 (2.2, 3.0)       1.8 (1.6, 2.3)                  1.1 (0.9, 1.3)                      1.7 (1.3, 2.1)
   FEV~1~ (% pred)[a](#tfn2-copd-11-2785){ref-type="table-fn"}                            97.0 (86.0, 106.0)   66.0 (57.0, 78.0)               40.5 (37.0, 45.0)                   65.0 (57.0, 77.0)
   FEV~1~/FVC[a](#tfn2-copd-11-2785){ref-type="table-fn"}                                 0.78 (0.75, 0.81)    0.62 (0.56, 0.65)               0.46 (0.38, 0.56)                   0.79 (0.75, 0.85)
   DLco (% pred)[b](#tfn3-copd-11-2785){ref-type="table-fn"}                              74.8±15.1            69.1±22.1                       48.0±18.2                           55.6±16.5

**Notes:** Data are presented as numbers (%) unless otherwise indicated.

Median (interquartile range)

mean ± standard deviation. COPD grade is defined as follows: mild-to-moderate COPD, FEV~1~ ≥50% predicted with FEV~1~/FVC \<0.7; severe-to-very-severe COPD, FEV~1~ \<50% predicted with FEV~1~/FVC \<0.7. Restrictive disease is defined as FVC \<80% predicted with FEV~1~/FVC ≥0.7.

**Abbreviations:** ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; DLco, diffusing capacity for carbon monoxide; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; mMRC, modified Medical Research Council Dyspnea Scale; pred, predicted.

###### 

Characteristics of abdominal surgery performed on study subjects

                                                                               Control (n=86)         Mild-to-moderate COPD (n=117)   Severe-to-very severe COPD (n=34)   Restrictive (n=150)
  ---------------------------------------------------------------------------- ---------------------- ------------------------------- ----------------------------------- ----------------------
  Emergency surgery                                                            7 (8.1)                11 (9.4)                        4 (11.8)                            19 (12.7)
  Anesthesia time (min)[a](#tfn6-copd-11-2785){ref-type="table-fn"}            240.5 (143.0, 335.0)   233.0 (116.0, 319.0)            148.0 (101.0, 190.0)                187.5 (110.0, 362.0)
  Incision to closure time (min)[a](#tfn6-copd-11-2785){ref-type="table-fn"}   169.0 (92.0, 269.0)    175.0 (77.0, 250.0)             106.5 (64.0, 145.0)                 129.0 (66.0, 292.0)
  Laparoscopic surgery                                                         24 (27.9)              43 (36.8)                       18 (52.9)                           60 (40.0)
  Upper abdominal surgery                                                      53 (61.6)              87 (74.4)                       26 (76.5)                           109 (72.7)
  RBCs for transfusion (pack)[a](#tfn6-copd-11-2785){ref-type="table-fn"}      2.0 (2.0, 2.0)         2.0 (2.0, 2.0)                  1.0 (0.0, 2.0)                      2.0 (0.0, 4.0)

**Notes:** Data are presented as numbers (%) unless otherwise indicated.

Median (interquartile range). COPD grade is defined as follows: mild-to-moderate COPD, FEV~1~ ≥50% predicted with FEV~1~/FVC \<0.7; severe-to-very severe COPD, FEV~1~ \<50% predicted with FEV~1~/FVC \<0.7. Restrictive disease is defined as FVC \<80% predicted with FEV~1~/FVC ≥0.7.

**Abbreviations:** COPD, chronic obstructive pulmonary disease; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; RBC, red blood cell.

###### 

Postoperative pulmonary complications and management

                                                                                       Control (n=86)      Mild-to-moderate COPD (n=117)   Severe-to-very-severe COPD (n=34)   Restrictive (n=150)   *P*-value
  ------------------------------------------------------------------------------------ ------------------- ------------------------------- ----------------------------------- --------------------- -----------
  Postoperative pulmonary complications                                                13 (15.1)           14 (12.0)                       9 (26.5)                            27 (18.0)             0.204
  Pneumonia                                                                            9 (10.5)            7 (6.0)                         4 (11.8)                            12 (8.0)              0.590
  Pulmonary edema                                                                      3 (3.5)             5 (4.3)                         4 (11.8)                            13 (8.7)              0.174
  Pulmonary thromboembolism                                                            1 (1.2)             0 (0.0)                         0 (0.0)                             1 (0.7)               0.671
  Atelectasis                                                                          4 (4.7)             3 (2.6)                         2 (5.9)                             10 (6.7)              0.484
  Acute exacerbation of COPD                                                           0 (0.0)             1 (0.9)                         0 (0.0)                             0 (0.0)               0.510
  ICU admission                                                                        11 (12.8)           11 (9.4)                        12 (35.3)                           47 (31.3)             \<0.001
  ICU admission due to respiratory cause                                               5 (45.5)            3 (27.3)                        3 (27.3)                            15 (31.9)             0.772
  Length of ICU admission (days)[a](#tfn9-copd-11-2785){ref-type="table-fn"}           2.0 (2.0, 15.5)     4.0 (2.5, 20.5)                 1.0 (1.0, 3.5)                      7.0 (1.0, 15.5)       0.041
  Ventilator care                                                                      9 (10.5)            8 (6.8)                         5 (14.7)                            35 (23.3)             0.001
  Length of ventilator care (days)[a](#tfn9-copd-11-2785){ref-type="table-fn"}         2.0 (1.0, 13.0)     6.0 (2.0, 33.0)                 1.0 (1.0, 6.0)                      6.0 (2.0, 29.5)       0.214
  Ventilator care over 3 days                                                          4 (44.4)            5 (62.5)                        2 (40.0)                            23 (65.7)             0.526
  Readmission within 30 days                                                           10 (11.8)           6 (5.1)                         0 (0.0)                             15 (10.1)             0.081
  Readmission due to respiratory cause                                                 0 (0.0)             0 (0.0)                         0 (0.0)                             3 (20.0)              0.170
  In-hospital mortality                                                                2 (2.3)             4 (3.4)                         0 (0.0)                             3 (2.0)               0.683
  In-hospital mortality + mortality within 30 days                                     2 (2.4)             4 (3.4)                         0 (0.0)                             4 (2.7)               0.752
  Overall mortality                                                                    2 (2.4)             4 (3.4)                         1 (3.0)                             9 (6.1)               0.532
  Expired due to respiratory problems                                                  0 (0.0)             2 (50.0)                        0 (0.0)                             1 (11.1)              
  Duration operation to discharge (days)[a](#tfn9-copd-11-2785){ref-type="table-fn"}   9.0 (6.0, 14.0)     9.0 (5.0, 16.0)                 7.5 (4.0, 13.0)                     9.0 (5.0, 18.0)       0.431
  Duration admission to discharge (days)[a](#tfn9-copd-11-2785){ref-type="table-fn"}   17.0 (13.0, 25.0)   18.0 (11.0, 26.0)               16.0 (9.0, 19.0)                    19.0 (12.0, 33.0)     0.092

**Notes:** Data are presented as numbers (%) unless otherwise indicated.

Median (interquartile range). COPD grade is defined as follows: mild-to-moderate COPD, FEV~1~ ≥50% predicted with FEV~1~/FVC \<0.7; severe-to-very severe COPD, FEV~1~ \<50% predicted with FEV~1~/FVC \<0.7. Restrictive disease is defined as FVC \<80% predicted with FEV~1~/FVC ≥0.7.

**Abbreviations:** COPD, chronic obstructive pulmonary disease; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; ICU, intensive care unit.

###### 

Risk factors for postoperative pulmonary complications in all subjects

                                                             Univariate                                                             Multivariate (all variables entered)                                 Multivariate (stepwise backward elimination)
  ---------------------------------------------------------- ---------------------------------------------------------------------- -------------------------------------------------------------------- ---------------------------------------------------------------------
  Age                                                        0.99 (0.97--1.02)                                                      1.04 (1.00--1.08)                                                    
  Gender (male)                                              0.58 (0.30--1.05)                                                      1.59 (0.72--3.55)                                                    
  Body mass index                                            0.96 (0.89--1.03)                                                      0.97 (0.88--1.06)                                                    
  Charlson comorbidity index                                 1.19 (1.03--1.36)[\*](#tfn12-copd-11-2785){ref-type="table-fn"}        1.05 (0.87--1.27)                                                    
  ASA physical status                                        2.57 (1.76--3.80)[\*\*\*](#tfn14-copd-11-2785){ref-type="table-fn"}    1.52 (0.90--2.58)                                                    1.60 (0.97--2.63)
  Hospitalization within 1 year due to respiratory illness   3.43 (1.38--8.12)[\*\*](#tfn13-copd-11-2785){ref-type="table-fn"}      3.77 (1.35--10.57)[\*](#tfn12-copd-11-2785){ref-type="table-fn"}     4.20 (1.52--11.59)[\*\*](#tfn13-copd-11-2785){ref-type="table-fn"}
  BUN                                                        1.03 (1.01--1.05)[\*\*](#tfn13-copd-11-2785){ref-type="table-fn"}      1.00 (0.98--1.03)                                                    
  Emergency surgery                                          5.93 (2.96--11.85)[\*\*\*](#tfn14-copd-11-2785){ref-type="table-fn"}   4.28 (1.82--10.05)[\*\*](#tfn13-copd-11-2785){ref-type="table-fn"}   3.93 (1.75--8.82)[\*\*](#tfn13-copd-11-2785){ref-type="table-fn"}
  Anesthesia time                                            1.00 (1.00--1.00)[\*\*\*](#tfn14-copd-11-2785){ref-type="table-fn"}    1.00 (1.00--1.00)                                                    
  Laparoscopic surgery                                       0.26 (0.12--0.52)[\*\*\*](#tfn14-copd-11-2785){ref-type="table-fn"}    0.52 (0.21--1.24)                                                    0.41 (0.18--0.93)[\*](#tfn12-copd-11-2785){ref-type="table-fn"}
  Upper abdominal surgery                                    1.02 (0.57--1.89)                                                      0.79 (0.36--1.72)                                                    
  RBCs for transfusion                                       1.12 (1.08--1.17)[\*\*\*](#tfn14-copd-11-2785){ref-type="table-fn"}    1.09 (1.02--1.16)[\*\*](#tfn13-copd-11-2785){ref-type="table-fn"}    1.09 (1.05--1.14)[\*\*\*](#tfn14-copd-11-2785){ref-type="table-fn"}
  Mild-to-moderate COPD                                      0.76 (0.34--1.72)                                                      0.57 (0.21--1.59)                                                    0.79 (0.31--2.03)
  Severe-to-very severe COPD                                 2.02 (0.77--5.30)                                                      2.27 (0.68--7.56)                                                    3.47 (1.16--10.42)[\*](#tfn12-copd-11-2785){ref-type="table-fn"}
  Restrictive disease                                        1.23 (0.60--2.54)                                                      0.71 (0.28--1.77)                                                    0.81 (0.33--1.97)

**Notes:** COPD grade is defined as follows: mild-to-moderate COPD, FEV~1~ ≥50% predicted with FEV~1~/FVC \<0.7; severe-to-very-severe COPD, FEV~1~ \<50% predicted with FEV~1~/FVC \<0.7. Restrictive disease is defined as FVC \<80% predicted with FEV~1~/FVC ≥0.7.

*P*\<0.05;

*P*\<0.01;

*P*\<0.001.

**Abbreviations:** ASA, American Society of Anesthesiologists; BUN, blood urea nitrogen; CI, confidence interval; COPD, chronic obstructive pulmonary disease; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; OR, odds ratio; RBC, red blood cell.

###### 

Risk factors for postoperative pulmonary complications only in ever-smokers without restrictive pattern (a subgroup analysis)

                                                             Univariate                                                              Multivariate (all variables entered)                                   Multivariate (stepwise elimination)
  ---------------------------------------------------------- ----------------------------------------------------------------------- ---------------------------------------------------------------------- ----------------------------------------------------------------------
  Age                                                        1.01 (0.95--1.07)                                                       1.06 (0.97--1.17)                                                      
  Body mass index                                            0.91 (0.77--1.08)                                                       0.91 (0.72--1.16)                                                      
  Charlson comorbidity index                                 1.17 (0.92--1.48)                                                       1.24 (0.89--1.73)                                                      
  ASA physical status                                        2.14 (1.07--4.27)[\*](#tfn17-copd-11-2785){ref-type="table-fn"}         0.92 (0.26--3.22)                                                      
  Hospitalization within 1 year due to respiratory illness   14.25 (3.42--73.03)[\*\*\*](#tfn19-copd-11-2785){ref-type="table-fn"}   28.21 (3.85--206.51)[\*\*](#tfn18-copd-11-2785){ref-type="table-fn"}   18.75 (3.47--101.25)[\*\*](#tfn18-copd-11-2785){ref-type="table-fn"}
  BUN                                                        1.03 (0.98--1.07)                                                       0.97 (0.88--1.07)                                                      
  Emergency surgery                                          5.11 (1.51--16.71)[\*\*](#tfn18-copd-11-2785){ref-type="table-fn"}      3.95 (0.73--21.43)                                                     3.92 (0.89--17.26)
  Anesthesia time                                            1.00 (1.00--1.01)[\*\*](#tfn18-copd-11-2785){ref-type="table-fn"}       1.00 (0.99--1.01)                                                      
  Laparoscopic surgery                                       0.33 (0.07--1.04)                                                       0.27 (0.05--1.68)                                                      
  Upper abdominal surgery                                    1.02 (0.36--3.33)                                                       1.67 (0.33--8.54)                                                      
  RBCs for transfusion                                       1.14 (1.06--1.31)[\*](#tfn17-copd-11-2785){ref-type="table-fn"}         1.20 (0.95--1.53)                                                      1.17 (1.02--1.34)[\*](#tfn17-copd-11-2785){ref-type="table-fn"}
  Mild-to-moderate COPD                                      0.42 (0.13--1.34)                                                       0.26 (0.05--1.39)                                                      0.34 (0.08--1.50)
  Severe-to-very-severe COPD                                 1.46 (0.43--4.91)                                                       2.06 (0.35--12.01)                                                     1.85 (0.42--8.24)

**Notes:** COPD grade is defined as follows: mild-to-moderate COPD, FEV~1~ ≥50% predicted with FEV~1~/FVC \<0.7; severe-to-very-severe COPD, FEV~1~ \<50% predicted with FEV~1~/FVC \<0.7. Restrictive disease is defined as FVC \<80% predicted with FEV~1~/FVC ≥0.7.

*P*\<0.05;

*P*\<0.01;

*P*\<0.001. The variable Gender (male) was omitted in this table, because the subgroup had only 2 female patients.

**Abbreviations:** ASA, American Society of Anesthesiologists; BUN, blood urea nitrogen; CI, confidence interval; COPD, chronic obstructive pulmonary disease; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; OR, odds ratio; RBC, red blood cell.
